Table 2.
Outcomes for Emergent and Less Frequent Therapeutics and Surgeries.
| Treatment | Patient # | ASIA Score | Death | Worsened | No Change | Some Improvement | Mostly Improved | Full Improvement |
|---|---|---|---|---|---|---|---|---|
| Treatment | ||||||||
| HBO | 1 | B | x | |||||
| 2 | A | x | ||||||
| 3 | A | x | ||||||
| 4 | C | x | ||||||
| 5 | A | x | ||||||
| 6 | A | x | ||||||
| 7 | A | x | ||||||
| 8 | A | x | ||||||
| Hemoglobin Transfusion | 1 | A | x | |||||
| 2 | C | x | ||||||
| 3 | C | x | ||||||
| 4 | B | x | ||||||
| Edavarone | 1 | B | x | |||||
| 2 | C | x | ||||||
| Mannitol | 1 | A | x | |||||
| 2 | B | x | ||||||
| 3 | A | x | ||||||
| 4 | C | x | ||||||
| Naloxone | 1 | C | x | |||||
| 2 | C | x | ||||||
| Therapeutic Surgery | ||||||||
| Endovascular Revascularization Procedure | 1 | A | x | |||||
| 2 | A | x | ||||||
| 3 | A | x* | ||||||
| 4 | D | x | ||||||
| 5 | A | x | ||||||
| Open Revascularization | 1 | B | x | |||||
| 2 | D | x | ||||||
| 3 | A | x | ||||||
| 4 | A | x | ||||||
| 5 | A | x | ||||||
| 6 | A | x | ||||||
| Discectomy/ | ||||||||
| Laminectomy/ | ||||||||
| Laminoplasty | 1 | B | x | |||||
| 2 | B | x | ||||||
| 3 | A | x* | ||||||
| Removal of Pathology (tumor, AVM, hematoma) | 1 | B | x |
x* refers to the same patient with both procedures.